Diversity and function of group 1 innate lymphoid cells

Immunology Letters

Volumn 179, Issue , 2016, Pages 19-24

  Cortez, Victor S ^a   Colonna, Marco ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ILC; Innate immunity; Interferon gamma; NK cells

Indexed keywords

EOMESODERMIN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 5; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; BIOLOGICAL MARKER; CYTOKINE;

CELL DIVERSITY; CELL FUNCTION; CELL HETEROGENEITY; CELL LINEAGE; CELL MATURATION; CELL SUBPOPULATION; CELLULAR PARAMETERS; CYTOKINE RELEASE; DEVELOPMENTAL STAGE; GROUP 1 INNATE LYMPHOID CELL; GROUP 2 INNATE LYMPHOID CELL; GROUP 3 INNATE LYMPHOID CELL; HUMAN; LYMPHOID CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SALIVARY GLAND; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL PLASTICITY; CYTOLOGY; DISEASE PREDISPOSITION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; METABOLISM;

ANIMALS; BIOMARKERS; CELL DIFFERENTIATION; CELL PLASTICITY; CYTOKINES; DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; ORGAN SPECIFICITY; PHENOTYPE; TRANSCRIPTION FACTORS;

EID: 84994036949     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2016.07.005     Document Type: Review

References (62)

1. [1] Antonioli, L., Pacher, P., Vizi, E.S., Haskó, G., CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 19 (2013), 355–367.
2. [2] Boulenouar, S., Doisne, J.-M., Sferruzzi-Perri, A., Gaynor, L.M., Kieckbusch, J., Balmas, E., Yung, H.W., Javadzadeh, S., Volmer, L., Hawkes, D.A., et al. The residual innate lymphoid cells in NFIL3-deficient mice support suboptimal maternal adaptations to pregnancy. Front. Immunol., 7, 2016, 43.
3. [3] Brandtzaeg, P., Do salivary antibodies reliably reflect both mucosal and systemic immunity?. Ann. N. Y. Acad. Sci. 1098 (2007), 288–311.
4. [4] Cai, S.F., Fehniger, T.A., Cao, X., Mayer, J.C., Brune, J.D., French, A.R., Ley, T.J., Differential expression of granzyme B and C in murine cytotoxic lymphocytes. J. Immunol. Baltim. Md 1950:182 (2009), 6287–6297.
5. [5] Carbone, F.R., Mackay, L.K., Heath, W.R., Gebhardt, T., Distinct resident and recirculating memory T cell subsets in non-lymphoid tissues. Curr. Opin. Immunol. 25 (2013), 329–333.
6. [6] Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J.K.M., Doherty, J.M., Mills, J.C., Colonna, M., A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457 (2009), 722–725.
7. [7] Cella, M., Miller, H., Song, C., Beyond NK cells: the expanding universe of innate lymphoid cells. Front. Immunol., 5, 2014, 282.
8. [8] Chea, S., Possot, C., Perchet, T., Petit, M., Cumano, A., Golub, R., CXCR6 expression is important for retention and circulation of ILC precursors. Mediators Inflamm., 2015, 2015, 368427.
9. [9] Colonna, M., Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31 (2009), 15–23.
10. [10] Commins, S.P., Mechanisms of oral tolerance. Pediatr. Clin. North Am. 62 (2015), 1523–1529.
11. [11] Constantinides, M.G., McDonald, B.D., Verhoef, P.A., Bendelac, A., A committed precursor to innate lymphoid cells. Nature 508 (2014), 397–401.
12. [12] Constantinides, M.G., Gudjonson, H., McDonald, B.D., Ishizuka, I.E., Verhoef, P.A., Dinner, A.R., Bendelac, A., PLZF expression maps the early stages of ILC1 lineage development. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 5123–5128.
13. [13] Cortez, V.S., Fuchs, A., Cella, M., Gilfillan, S., Colonna, M., Cutting edge: salivary gland NK cells develop independently of Nfil3 in steady-state. J. Immunol. Baltim. Md 195:192 (2014), 4487–4491.
14. [14] Cortez, V.S., Robinette, M.L., Colonna, M., Innate lymphoid cells: new insights into function and development. Curr. Opin. Immunol. 32 (2015), 71–77.
15. [15] Crotta, S., Gkioka, A., Male, V., Duarte, J.H., Davidson, S., Nisoli, I., Brady, H.J.M., Wack, A., The transcription factor E4BP4 is not required for extramedullary pathways of NK cell development. J. Immunol. Baltim. Md 1950:192 (2014), 2677–2688.
16. [16] Daussy, C., Faure, F., Mayol, K., Viel, S., Gasteiger, G., Charrier, E., Bienvenu, J., Henry, T., Debien, E., Hasan, U.A., et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J. Exp. Med. 211 (2014), 563–577.
17. [17] Diefenbach, A., Colonna, M., Koyasu, S., Development, differentiation, and diversity of innate lymphoid cells. Immunity 41 (2014), 354–365.
18. [18] Fábián, T.K., Hermann, P., Beck, A., Fejérdy, P., Fábián, G., Salivary defense proteins: their network and role in innate and acquired oral immunity. Int. J. Mol. Sci. 13 (2012), 4295–4320.
19. [19] Feller, L., Altini, M., Khammissa, R.A.G., Chandran, R., Bouckaert, M., Lemmer, J., Oral mucosal immunity. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 116 (2013), 576–583.
20. [20] Firth, M.A., Madera, S., Beaulieu, A.M., Gasteiger, G., Castillo, E.F., Schluns, K.S., Kubo, M., Rothman, P.B., Vivier, E., Sun, J.C., Nfil3-independent lineage maintenance and antiviral response of natural killer cells. J. Exp. Med. 210 (2013), 2981–2990.
21. [21] Fuchs, A., Vermi, W., Lee, J.S., Lonardi, S., Gilfillan, S., Newberry, R.D., Cella, M., Colonna, M., Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity 38 (2013), 769–781.
22. [22] Gascoyne, D.M., Long, E., Veiga-Fernandes, H., de Boer, J., Williams, O., Seddon, B., Coles, M., Kioussis, D., Brady, H.J.M., The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 10 (2009), 1118–1124.
23. [23] Gasteiger, G., Fan, X., Dikiy, S., Lee, S.Y., Rudensky, A.Y., Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350 (2015), 981–985.
24. [24] Geiger, T.L., Sun, J.C., Development and maturation of natural killer cells. Curr. Opin. Immunol. 39 (2016), 82–89.
25. [25] Geiger, T.L., Abt, M.C., Gasteiger, G., Firth, M.A., O'Connor, M.H., Geary, C.D., O'sullivan, T.E., van den Brink, M.R., Pamer, E.G., Hanash, A.M., et al. Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. J. Exp. Med. 211 (2014), 1723–1731.
26. [26] Getachew, Y., Stout-Delgado, H., Miller, B.C., Thiele, D.L., Granzyme C supports efficient CTL-mediated killing late in primary alloimmune responses. J. Immunol. Baltim. Md 1950:181 (2008), 7810–7817.
27. [27] Gonzaga, R., Matzinger, P., Perez-Diez, A., Resident peritoneal NK cells. J. Immunol. Baltim. Md 1950:187 (2011), 6235–6242.
28. [28] Gordon, S.M., Chaix, J., Rupp, L.J., Wu, J., Madera, S., Sun, J.C., Lindsten, T., Reiner, S.L., The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36 (2012), 55–67.
29. [29] Johnson, H., Scorrano, L., Korsmeyer, S.J., Ley, T.J., Cell death induced by granzyme C. Blood 101 (2003), 3093–3101.
30. [30] Kamizono, S., Duncan, G.S., Seidel, M.G., Morimoto, A., Hamada, K., Grosveld, G., Akashi, K., Lind, E.F., Haight, J.P., Ohashi, P.S., et al. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J. Exp. Med. 206 (2009), 2977–2986.
31. [31] Kim, S., Iizuka, K., Kang, H.-S.P., Dokun, A., French, A.R., Greco, S., Yokoyama, W.M., In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3 (2002), 523–528.
32. [32] Kirchberger, S., Royston, D.J., Boulard, O., Thornton, E., Franchini, F., Szabady, R.L., Harrison, O., Powrie, F., Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J. Exp. Med. 210 (2013), 917–931.
33. [33] Klose, C.S.N., Kiss, E.A., Schwierzeck, V., Ebert, K., Hoyler, T., d'Hargues, Y., Göppert, N., Croxford, A.L., Waisman, A., Tanriver, Y., et al. A T-bet gradient controls the fate and function of CCR6-ROR(t+ innate lymphoid cells. Nature 494 (2013), 261–265.
34. [34] Klose, C.S.N., Flach, M., Möhle, L., Rogell, L., Hoyler, T., Ebert, K., Fabiunke, C., Pfeifer, D., Sexl, V., Fonseca-Pereira, D., et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157 (2014), 340–356.
35. [35] Lee, J.S., Cella, M., Colonna, M., AHR and the transcriptional regulation of type-17/22 ILC. Front. Immunol., 3, 2012, 10.
36. [36] Lee, J.S., Cella, M., McDonald, K.G., Garlanda, C., Kennedy, G.D., Nukaya, M., Mantovani, A., Kopan, R., Bradfield, C.A., Newberry, R.D., et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13 (2012), 144–151.
37. [37] Mackay, L.K., Rahimpour, A., Ma, J.Z., Collins, N., Stock, A.T., Hafon, M.-L., Vega-Ramos, J., Lauzurica, P., Mueller, S.N., Stefanovic, T., et al. The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat. Immunol. 14 (2013), 1294–1301.
38. [38] Meharra, E.J., Schön, M., Hassett, D., Parker, C., Havran, W., Gardner, H., Reduced gut intraepithelial lymphocytes in VLA1 null mice. Cell. Immunol. 201 (2000), 1–5.
39. [39] Novak, N., Haberstok, J., Bieber, T., Allam, J.-P., The immune privilege of the oral mucosa. Trends Mol. Med. 14 (2008), 191–198.
40. [40] Pikovskaya, O., Chaix, J., Rothman, N.J., Collins, A., Chen, Y.-H., Scipioni, A.M., Vivier, E., Reiner, S.L., Cutting edge: eomesodermin is sufficient to direct type 1 innate lymphocyte development into the conventional NK lineage. J. Immunol. Baltim. Md 195:196 (2016), 1449–1454.
41. [41] Robinette, M.L., Fuchs, A., Cortez, V.S., Lee, J.S., Wang, Y., Durum, S.K., Gilfillan, S., Colonna, M., Immunological Genome Consortium, Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat. Immunol. 16 (2015), 306–317.
42. [42] Rosen, S.D., Ligands for L-selectin: homing, inflammation, and beyond. Annu. Rev. Immunol. 22 (2004), 129–156.
43. [43] Satoh-Takayama, N., Serafini, N., Verrier, T., Rekiki, A., Renauld, J.-C., Frankel, G., Di Santo, J.P., The chemokine receptor CXCR6 controls the functional topography of interleukin-22 producing intestinal innate lymphoid cells. Immunity 41 (2014), 776–788.
44. [44] Seillet, C., Huntington, N.D., Gangatirkar, P., Axelsson, E., Minnich, M., Brady, H.J.M., Busslinger, M., Smyth, M.J., Belz, G.T., Carotta, S., Differential requirement for Nfil3 during NK cell development. J. Immunol. Baltim. Md 1950:192 (2014), 2667–2676.
45. [45] Seillet, C., Rankin, L.C., Groom, J.R., Mielke, L.A., Tellier, J., Chopin, M., Huntington, N.D., Belz, G.T., Carotta, S., Nfil3 is required for the development of all innate lymphoid cell subsets. J. Exp. Med. 211 (2014), 1733–1740.
46. [46] Serafini, N., Klein Wolterink, R.G.J., Satoh-Takayama, N., Xu, W., Vosshenrich, C.A.J., Hendriks, R.W., Di Santo, J.P., Gata3 drives development of RORγt+ group 3 innate lymphoid cells. J. Exp. Med. 211 (2014), 199–208.
47. [47] Shiow, L.R., Rosen, D.B., Brdicková, N., Xu, Y., An, J., Lanier, L.L., Cyster, J.G., Matloubian, M., CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440 (2006), 540–544.
48. [48] Sojka, D.K., Tian, Z., Yokoyama, W.M., Tissue-resident natural killer cells and their potential diversity. Semin. Immunol. 26 (2014), 127–131.
49. [49] Sojka, D.K., Plougastel-Douglas, B., Yang, L., Pak-Wittel, M.A., Artyomov, M.N., Ivanova, Y., Zhong, C., Chase, J.M., Rothman, P.B., Yu, J., et al. Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. eLife, 3, 2014, e01659.
50. [50] Song, C., Lee, J.S., Gilfillan, S., Robinette, M.L., Newberry, R.D., Stappenbeck, T.S., Mack, M., Cella, M., Colonna, M., Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation. J. Exp. Med. 212 (2015), 1869–1882.
51. + T cells. Nat. Rev. Immunol. 11 (2011), 645–657.
52. [52] Tait Wojno, E.D., Artis, D., Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine. Cell Host Microbe 12 (2012), 445–457.
53. [53] Takeda, K., Cretney, E., Hayakawa, Y., Ota, T., Akiba, H., Ogasawara, K., Yagita, H., Kinoshita, K., Okumura, K., Smyth, M.J., TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 105 (2005), 2082–2089.
54. [54] Teeuw, W., Bosch, J.A., Veerman, E.C.I., Amerongen, A.V.N., Neuroendocrine regulation of salivary IgA synthesis and secretion: implications for oral health. Biol. Chem. 385 (2004), 1137–1146.
55. [55] Tessmer, M.S., Reilly, E.C., Brossay, L., Salivary gland NK cells are phenotypically and functionally unique. PLoS Pathog., 7, 2011, e1001254.
56. [56] Treuting, P.M., Dintzis, S.M., 8−Salivary glands. Comparative Anatomy and Histology, 2012, Academic Press, San Diego, 111–120.
57. [57] Xu, W., Domingues, R.G., Fonseca-Pereira, D., Ferreira, M., Ribeiro, H., Lopez-Lastra, S., Motomura, Y., Moreira-Santos, L., Bihl, F., Braud, V., et al. NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors. Cell Rep. 10 (2015), 2043–2054.
58. [58] Yagi, R., Zhong, C., Northrup, D.L., Yu, F., Bouladoux, N., Spencer, S., Hu, G., Barron, L., Sharma, S., Nakayama, T., et al. The transcription factor GATA3 is critical for the development of all IL-7Rα-Expressing innate lymphoid cells. Immunity 40 (2014), 378–388.
59. [59] Yokoyama, W.M., Kim, S., French, A.R., The dynamic life of natural killer cells. Annu. Rev. Immunol. 22 (2004), 405–429.
60. [60] Yu, X., Wang, Y., Deng, M., Li, Y., Ruhn, K.A., Zhang, C.C., Hooper, L.V., The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor. eLife, 2014, 3.
61. [61] Zhang, N., Bevan, M.J., Transforming growth factor-β signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. Immunity 39 (2013), 687–696.
62. [62] Zhong, C., Cui, K., Wilhelm, C., Hu, G., Mao, K., Belkaid, Y., Zhao, K., Zhu, J., Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment. Nat. Immunol. 17 (2016), 169–178.